Atlantic International Corp. (ATLN)
USD 5.32
(5.35%)
USD 5.32
(5.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -5.38 Million USD | -46.9% |
| 2022 | -3.8 Million USD | -54.22% |
| 2021 | -3.4 Million USD | -192.78% |
| 2020 | -649.39 Thousand USD | 61.24% |
| 2019 | -2.16 Million USD | 7.18% |
| 2018 | -2.59 Million USD | -60.71% |
| 2017 | -1.45 Million USD | -8.84% |
| 2016 | -1.33 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.02 Million USD | 13.91% |
| 2024 Q2 | -7.06 Million USD | -6493.31% |
| 2023 Q1 | -1.71 Million USD | -42.45% |
| 2023 Q2 | -1.39 Million USD | 18.91% |
| 2023 Q4 | -1.2 Million USD | 3.82% |
| 2023 FY | - USD | -46.9% |
| 2023 Q3 | -1.24 Million USD | 10.33% |
| 2022 Q1 | -827.84 Thousand USD | 38.69% |
| 2022 Q3 | -859.72 Thousand USD | 5.01% |
| 2022 Q2 | -905.09 Thousand USD | -9.33% |
| 2022 FY | - USD | -54.22% |
| 2022 Q4 | -1.2 Million USD | -40.11% |
| 2021 Q4 | -1.35 Million USD | -252.37% |
| 2021 FY | - USD | -192.78% |
| 2021 Q3 | -383.21 Thousand USD | 0.0% |
| 2020 FY | - USD | 61.24% |
| 2019 FY | - USD | 7.18% |
| 2018 FY | - USD | -60.71% |
| 2017 FY | - USD | -8.84% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -363.419% |
| Arrayit Corporation | -3.07 Million USD | -75.128% |
| Biocept, Inc. | -30.24 Million USD | 82.178% |
| Bioqual, Inc. | 3.03 Million USD | 277.742% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -611.61% |
| DermTech, Inc. | -97.89 Million USD | 94.494% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.185% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 73.375% |
| iMD Companies, Inc. | -154.65 Thousand USD | -3384.802% |
| IDenta Corp. | 71.58 Thousand USD | 7628.685% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 240.463% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 14030.111% |
| InVitro International | 6680.00 USD | 80782.036% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 0.854% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -44317.01% |
| Medical Imaging Corp. | -896.74 Thousand USD | -501.016% |
| NovelStem International Corp. | -3.78 Million USD | -42.363% |
| Optigenex Inc. | -1.18 Million USD | -354.154% |
| PharmChem, Inc. | 1.05 Million USD | 611.436% |
| Proteome Sciences plc | -1.13 Million USD | -374.016% |
| Response Genetics, Inc | -19.66 Million USD | 72.595% |
| Rennova Health, Inc. | -234.81 Thousand USD | -2195.237% |
| RushNet, Inc. | -614.85 Thousand USD | -776.562% |
| ScreenPro Security Inc. | -3.43 Million USD | -56.906% |
| Stella Diagnostics Inc. | -5.7 Million USD | 5.569% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 47.522% |
| Todos Medical Ltd. | -9.39 Million USD | 42.628% |